These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 11607821)
1. E2A-HLF usurps control of evolutionarily conserved survival pathways. Seidel MG; Look AT Oncogene; 2001 Sep; 20(40):5718-25. PubMed ID: 11607821 [TBL] [Abstract][Full Text] [Related]
2. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228 [TBL] [Abstract][Full Text] [Related]
3. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal. Chen W; Yu YL; Lee SF; Chiang YJ; Chao JR; Huang JH; Chiong JH; Huang CJ; Lai MZ; Yang-Yen HF; Yen JJ Mol Cell Biol; 2001 Jul; 21(14):4636-46. PubMed ID: 11416141 [TBL] [Abstract][Full Text] [Related]
4. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells. Yeung J; O'Sullivan E; Hubank M; Brady HJ Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370 [TBL] [Abstract][Full Text] [Related]
5. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia. Yamasaki N; Miyazaki K; Nagamachi A; Koller R; Oda H; Miyazaki M; Sasaki T; Honda ZI; Wolff L; Inaba T; Honda H Oncogene; 2010 Apr; 29(13):1963-75. PubMed ID: 20062079 [TBL] [Abstract][Full Text] [Related]
6. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF. Inukai T; Inaba T; Ikushima S; Look AT Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120 [TBL] [Abstract][Full Text] [Related]
8. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors. de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044 [TBL] [Abstract][Full Text] [Related]
9. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein. Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688 [TBL] [Abstract][Full Text] [Related]
10. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains. LeBrun DP; Matthews BP; Feldman BJ; Cleary ML Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523 [TBL] [Abstract][Full Text] [Related]
11. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression. Baudis M; Prima V; Tung YH; Hunger SP Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189 [TBL] [Abstract][Full Text] [Related]
15. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Hunger SP; Ohyashiki K; Toyama K; Cleary ML Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826 [TBL] [Abstract][Full Text] [Related]
16. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Inukai T; Inoue A; Kurosawa H; Goi K; Shinjyo T; Ozawa K; Mao M; Inaba T; Look AT Mol Cell; 1999 Sep; 4(3):343-52. PubMed ID: 10518215 [TBL] [Abstract][Full Text] [Related]
17. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF. Hunger SP; Brown R; Cleary ML Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331 [TBL] [Abstract][Full Text] [Related]
18. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties. Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829 [TBL] [Abstract][Full Text] [Related]
19. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice. Smith KS; Rhee JW; Naumovski L; Cleary ML Mol Cell Biol; 1999 Jun; 19(6):4443-51. PubMed ID: 10330184 [TBL] [Abstract][Full Text] [Related]
20. Critical role for a single leucine residue in leukemia induction by E2A-PBX1. Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]